BioSpace News Archive

DOTmed.com, the world’s leading online medical equipment marketplace, is launching a free service to help hospitals across the country support one another in their efforts to combat the novel coronavirus.

George Clinical, a global scientifically-backed clinical research organization, is leveraging the organization’s significant health and medical expertise, operational infrastructure and data science teams to actively advise stakeholders on potential COVID-19 vaccine and treatment studies.

Joerns Healthcare is doubling its healthcare bed and mattress production capacity to support customers and caregivers with critical care products necessary to meet COVID-19 patient needs.

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the company has submitted an Emergency Use Authorization (EUA) application to the U.S. Food and Drug Administration (FDA) to facilitate the study and clinical use of its gammaCore SapphireTM non-invasive vagus nerve stimulation therapy, or nVNS, for respiratory symptoms associated with COVID-19.

Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company developing novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced the appointment of Charles Bancroft to its board of directors.

Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will report first quarter 2020 financial results on Wednesday, April 29, 2020, after the close of market.

Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on Form 10-Q for the second quarter of its 2020 fiscal year, the period ended February 29, 2020, on Thursday, April 9, 2020.

Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”) announces that a total of 3,752 common shares will be issued at the rate of $0.61 per share to satisfy the maintenance fee of $2,280 owing in respect of the debentures issued on April 9, 2019.

Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”) announced today that, due to the emerging public health impact of the COVID-19 pandemic and to protect the health and safety of its partners and shareholders, the location of the Company’s 2020 annual meeting of shareholders (the “Annual Meeting”) has been changed and will be held in a virtual meeting format only

BioIQ, a healthcare engagement and clinical adherence technology platform company, announces the formation of a Public Health Advisory Board.